MARCY L’ETOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a global leader in the field of in vitro diagnostics, today released its business review for the nine months ended September 30, 2007. Financial review Sales Net sales amounted to €778.1 million in the first nine months of 2007, an increase of 6.9% at constant exchange rates and scope of consolidation (like-for-like).
